Effect of cytokines, dexamethazone and the A/T-signal peptide polymorphism on the expression of alpha1-antichymotrypsin in astrocytes: Significance for Alzheimer's disease

Neurochemistry International

Volumn 39, Issue 5-6, 2001, Pages 361-370

  Nilsson, Lars N G ^a   Das, Saumya ^b   Potter, Huntington ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Alpha 1 antichymotrypsin; Alzheimer's disease; Glucocorticoid; Inflammation; Interleukin 1; Interleukin 6; Polymorphism; Transforming growth factor beta 1

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; AMYLOID; CONTRAPSIN; DEXAMETHASONE; GLUCOCORTICOID; INTERLEUKIN 6; INTERLEUKIN 8; SIGNAL PEPTIDE; BUCLADESINE; CYTOKINE; GLUCOCORTICOID RECEPTOR; MESSENGER RNA; SERINE PROTEINASE INHIBITOR; TRYPSIN INHIBITOR;

ALLELE; ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; ASTROCYTE; ASTROCYTOMA; CELL LEVEL; CONTROLLED STUDY; DISEASE COURSE; DISEASE PREDISPOSITION; FIBROBLAST; GENE CONTROL; GENE EXPRESSION; GENETIC CODE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INFLAMMATION; NEUROPATHOLOGY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN POLYMORPHISM; PROTEIN SECRETION; PROTEIN SYNTHESIS; RAT; RISK FACTOR; ANIMAL; CELL CULTURE; DRUG EFFECT; GENETIC POLYMORPHISM; GENETICS; METABOLISM; PHYSIOLOGY;

ALPHA 1-ANTICHYMOTRYPSIN; ALZHEIMER DISEASE; ANIMALS; ASTROCYTES; BUCLADESINE; CELLS, CULTURED; CYTOKINES; DEXAMETHASONE; GLUCOCORTICOIDS; HUMANS; POLYMORPHISM, GENETIC; PROTEIN BIOSYNTHESIS; PROTEIN SORTING SIGNALS; RATS; RECEPTORS, GLUCOCORTICOID; RNA, MESSENGER; SERPINS; TRYPSIN INHIBITORS;

EID: 0034741128     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(01)00043-2     Document Type: Article

References (71)

1. 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease
2. 1-antichymotrypsin
3. Inflammation and Alzheimer's disease
4. Interleukin-6 and alpha-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices
5. Distinct sets of acute phase plasma proteins are stimulated by separate human hepatocyte-stimulating factors and monokines in rat hepatoma cells
6. Interaction among hepatocyte-stimulating factors, interleukin 1 and glucocorticoids for regulation of acute phase plasma proteins in human hepatoma (HepG2) cells
7. Transcriptional regulation through cytokine and glucocorticoid response element of rat acute phase plasma protein genes by C/EBP and JunB
8. The acute phase response
9. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin-6
10. Recombinant human interleukin-6 (IL-6/BSF-2/HSF) regulates the synthesis of acute phase proteins in human hepatocytes
11. 1-antitrypsin and antithrombin III
12. Isolation and characterization of amyloid P component form Alzheimer's disease and other types of cerebral amyloidosis
13. Expression of the Alzheimer amyloid-promoting factor antichymotrypsin is induced in human astrocytes by IL-1
14. Association of an interleukin 1alpha polymorphism with Alzheimer's disease
15. Immunodetection of the amyloid P component in Alzheimer's disease
16. 1-antichymotrypsin synthesis in astrocytes by preventing degradation of IκB-alpha
17. 1-Antichymotrypsin binding to Alzheimer Aβ peptides is sequence specific and induces fibril disaggregation in vitro
18. Brain interleukin-1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease
19. Association of early-onset Alzheimer's disease with an interleukin-1α gene polymorphism
20. 1-antichymotrypsin in Alzheimer disease
21. Accelerated evolution in the reactive centre regions of serine protease inhibitors
22. 2-Macroglobulin associates with β-amyloid peptide and prevents fibril formation
23. Demonstration of CRP immunoreactivity in brains of Alzheimer's disease: Immunohistochemical study using formic acid pretreatment of tissue section
24. 1-antichymotrypsin
25. Conservation of the sequence of the Alzheimer's disease amyloid peptide in dog, polar bear and five other mammals by cross-species polymerase chain reaction analysis
26. 1-antichymotrypsin polymorphism
27. The carboxy-terminal region of STAT3 controls gene induction by the mouse haptoglobin promoter
28. Rat contrapsin are the type II acute phase proteins: Regulation by interleukin-6 on the mRNA level
29. 1-antichymotrypsin expression in human cortical astrocytes
30. The phenomenon of the acute phase response
31. Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: Peripheral inflammation or signals from the brain?
32. Serum alpha 1-antichymotrypsin level as a marker for Alzheimer-type dementia
33. Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease
34. 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments
35. Alzheimer Abeta neurotoxicity: Promotion by antichymotrypsin. ApoE4; inhibition by A beta-related peptides
36. 1-antichymotrypsin expression in the human astrocytoma cell line U373 MG
37. Serum concentration of alpha 1-antichymotrypsin is elevated in patients with senile dementia of the Alzheimer type
38. Alpha 1-antichymotrypsin as a possible biochemical marker for Alzheimer-type dementia
39. Anti-inflammatory drugs and Alzheimer disease
40. Association of serum AACT levels and AACT signal polymorphism with late-onset Alzheimer's disease in Northern Ireland
41. A highly sensitive northern blot assay detects multiple proenkephalin A-like mRNAs in human caudate nucleus and pheocytochroma
42. Reduction of β-amyloid peptide 42 in the cerebrospinal fluid of patients with Alzheimer's disease
43. 1-antichymotrypsin enhances Alzheimer-like pathology in amyloid protein precursor transgenic mice
44. 1-antichymotrypsin polymorphism, Alzheimer's disease, and allele ε4 of apolipoprotein E
45. 1-antichymotrypsin polymorphism in familial Alzheimer's disease
46. Association of interleukin-1 gene polymorphisms with Alzheimer's disease
47. The essential role of inflammation and induced gene expression in the pathogenic pathway of Alzheimer's disease
48. Alpha-1-antichymotrypsin promotes β-sheet amyloid plaque deposition in a transgenic mouse model of Alzheimer's disease
49. Cerebrospinal fluid levels of the amyloid β-protein in Alzheimer's disease: Inverse correlation with severity of dementia and effect of apolipoprotein E genotype
50. A genetic variation of the inflammatory cytokine interleukin-6 delays the initial onset and reduces the risk for sporadic Alzheimer's disease
51. 1-antichymotrypsin mRNA
52. 1-antichymotrypsin in cerebral and systemic amyloid
53. Interleukin-6 induces a liver-specific nuclear protein that binds to the promoter of acute-phase genes
54. The involvment of proteases, protease inhibitors, and an acute phase response in Alzheimer's disease
55. Beyond beta-protein - The essential role of inflammation in Alzheimer amyloid formation
56. Morphological and biochemical analyses of amyloid plaque core proteins purified from Alzheimer disease brain tissue
57. Distribution pattern and functional state of aplha 1-antichymotrypsin in plaques and vascular amyloid in Alzheimer's disease. A immunohistochemical study with monoclonal antibodies against native and and inactivated alpha 1-antichymotrypsin
58. Conservation of brain amyloid proteins in aged mammals and humans with Alzheimer's disease
59. Microglial interleukin-1 alpha expression in brain regions in Alzheimer's disease: Correlation with neuritic plaque distribution
60. Intracellular adhesion molecule-1 gene expression by glial cells. Differential mechanisms of inhibition by interleukin-10 and interleukin-6
61. Detection of interleukin-6 and alpha 2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients
62. Polymorphism in AACT gene may lower age of onset of Alzheimer's disease
63. Enhanced expression of a glyceraldehyde-3-phosphate dehydrogenase gene in human lung cancers
64. Human plasma proteinase inhibitors
65. Apolipoprotein E: A pathological chaperone protein in patients with cerebral and systemic amyloid
66. Cytokine indices in Alzheimer's temporal cortex: No changes in mature IL-1beta or IL-1RA but increases in the associated acute phase proteins IL-6, alpha 2-macroglobulin and C-reactive protein
67. 1 in transgenic mice and in Alzheimer's disease
68. 1 by astrocytes promotes Alzheimer's disease-like microvascular degeneration in transgenic mice
69. 1-antichymotrypsin polymorphism with cerebral amyloid angiopathy
70. 1-Antichymotrypsin as a risk modifier for late-onset Alzheimer's disease in japanese apolipoprotein E ε4 allele carriers
71. STAT3 acts as a co-activator of glucocorticoid receptor signaling